12 research outputs found
Eta Carinae across the 2003.5 Minimum: Analysis in the visible and near infrared spectral region
We present an analysis of the visible through near infrared spectrum of Eta
Carinae and its ejecta obtained during the "Eta Carinae Campaign with the UVES
at the ESO VLT". This is a part of larger effort to present a complete Eta
Carinae spectrum, and extends the previously presented analyses with the
HST/STIS in the UV (1240-3159 A) to 10,430 A. The spectrum in the mid and near
UV is characterized by the ejecta absorption. At longer wavelengths, stellar
wind features from the central source and narrow emission lines from the
Weigelt condensations dominate the spectrum. However, narrow absorption lines
from the circumstellar shells are present. This paper provides a description of
the spectrum between 3060 and 10,430 A, including line identifications of the
ejecta absorption spectrum, the emission spectrum from the Weigelt
condensations and the P-Cygni stellar wind features. The high spectral
resolving power of VLT/UVES enables equivalent width measurements of atomic and
molecular absorption lines for elements with no transitions at the shorter
wavelengths. However, the ground based seeing and contributions of nebular
scattered radiation prevent direct comparison of measured equivalent widths in
the VLT/UVES and HST/STIS spectra. Fortunately, HST/STIS and VLT/UVES have a
small overlap in wavelength coverage which allows us to compare and adjust for
the difference in scattered radiation entering the instruments' apertures. This
paper provides a complete online VLT/UVES spectrum with line identifications
and a spectral comparison between HST/STIS and VLT/UVES between 3060 and 3160
A.Comment: 13 pages, 11 figures + atlas. The paper accepted for the ApJS and is
accompanied with an atlas in the online edition pape
Discovery of CH and OH in the -513 km s-1 Ejecta of Eta Carinae
The very massive star, Eta Carinae, is enshrouded in an unusual complex of
stellar ejecta, which is highly depleted in C and O, and enriched in He and N.
This circumstellar gas gives rise to distinct absorption components
corresponding to at least 20 different velocities along the line-of-sight. The
velocity component at -513 kms-1 exhibits very low ionization with
predominantly neutral species of iron-peak elements. Our statistical
equilibrium/photoionization modeling indicates that the low temperature (T =
760 K) and high density (n_H=10^7 cm^-3) of the -513 kms-1 component is
conducive to molecule formation including those with the elements C and O.
Examination of echelle spectra obtained with the Space Telescope Imaging
Spectrograph (STIS) aboard the confirms the model's predictions. The molecules,
H_2, CH, and most likely OH, have been identified in the -513 kms-1 absorption
spectrum. This paper presents the analysis of the HST/STIS spectra with the
deduced column densities for CH, OH and C I, and upper limit for CO. It is
quite extraordinary to see molecular species in a cool environment at such a
high velocity. The sharp molecular and ionic absorptions in this extensively
CNO- processed material offers us a unique environment for studying the
chemistry, dust formation processes, and nucleosynthesis in the ejected layers
of a highly evolved massive star.Comment: tentatively scheduled for the ApJ 1 September 2005, v630, 1 issu
Targeting Inaccurate Atomic Data in the Eta Car Ejecta Absorption
The input from the laboratory spectroscopist community has on many occasions helped the analysis of the eta Car spectrum. Our analysis has targeted spectra where improved wavelengths and oscillator strengths are needed. We will demonstrate how experimentally derived atomic data have improved our spectral analysis, and illuminate where more work still is needed
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism
ETA CARINAE ACROSS THE 2003.5 MINIMUM: ANALYSIS IN THE VISIBLE AND NEAR-INFRARED SPECTRAL REGION
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology (vol 11, 5881, 2020)
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism. Gut microbial metabolism of nutrients contributes to metabolic diseases, and the histidine metabolite imidazole propionate (ImP) is produced by type 2 diabetes (T2D) associated microbiome. Here the authors report that circulating ImP levels are increased in subjects with prediabetes or T2D in three European populations, and this increase associates with altered gut microbiota rather than dietary histidine